Narayana Hrudayalaya Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 20, 2025, 6:26 pm

Competitors of Narayana Hrudayalaya Ltd

All Competitor Stocks of Narayana Hrudayalaya Ltd

Quarterly Result

Last Updated: August 20, 2025, 6:25 am

Below is a detailed analysis of the quarterly data for Narayana Hrudayalaya Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,507.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,475.00 Cr. (Mar 2025) to 1,507.00 Cr., marking an increase of 32.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,171.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,118.00 Cr. (Mar 2025) to 1,171.00 Cr., marking an increase of 53.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 337.00 Cr.. The value appears to be declining and may need further review. It has decreased from 358.00 Cr. (Mar 2025) to 337.00 Cr., marking a decrease of 21.00 Cr..
• For OPM %, as of Jun 2025, the value is 22.00%. The value appears to be declining and may need further review. It has decreased from 24.00% (Mar 2025) to 22.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 4.00 Cr..
• For Interest, as of Jun 2025, the value is 45.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 41.00 Cr. (Mar 2025) to 45.00 Cr., marking an increase of 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 84.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 82.00 Cr. (Mar 2025) to 84.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 232.00 Cr.. The value appears to be declining and may need further review. It has decreased from 254.00 Cr. (Mar 2025) to 232.00 Cr., marking a decrease of 22.00 Cr..
• For Tax %, as of Jun 2025, the value is 15.00%. The value appears to be improving (decreasing) as expected. It has decreased from 22.00% (Mar 2025) to 15.00%, marking a decrease of 7.00%.
• For Net Profit, as of Jun 2025, the value is 197.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 197.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 9.62. The value appears to be declining and may need further review. It has decreased from 9.65 (Mar 2025) to 9.62, marking a decrease of 0.03.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:47 am

Growth

Last Updated: September 5, 2025, 11:30 am

Balance Sheet

Last Updated: September 10, 2025, 2:07 pm

Below is a detailed analysis of the balance sheet data for Narayana Hrudayalaya Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 204.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 204.00 Cr..
• For Reserves, as of Mar 2025, the value is 3,422.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,679.00 Cr. (Mar 2024) to 3,422.00 Cr., marking an increase of 743.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,428.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,627.00 Cr. (Mar 2024) to 2,428.00 Cr., marking an increase of 801.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,216.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,123.00 Cr. (Mar 2024) to 1,216.00 Cr., marking an increase of 93.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 7,271.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,633.00 Cr. (Mar 2024) to 7,271.00 Cr., marking an increase of 1,638.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 4,266.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,651.00 Cr. (Mar 2024) to 4,266.00 Cr., marking an increase of 1,615.00 Cr..
• For CWIP, as of Mar 2025, the value is 86.00 Cr.. The value appears to be declining and may need further review. It has decreased from 514.00 Cr. (Mar 2024) to 86.00 Cr., marking a decrease of 428.00 Cr..
• For Investments, as of Mar 2025, the value is 1,084.00 Cr.. The value appears strong and on an upward trend. It has increased from 844.00 Cr. (Mar 2024) to 1,084.00 Cr., marking an increase of 240.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,835.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,624.00 Cr. (Mar 2024) to 1,835.00 Cr., marking an increase of 211.00 Cr..
• For Total Assets, as of Mar 2025, the value is 7,271.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,633.00 Cr. (Mar 2024) to 7,271.00 Cr., marking an increase of 1,638.00 Cr..

Notably, the Reserves (3,422.00 Cr.) exceed the Borrowings (2,428.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Narayana Hrudayalaya Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 38.90. This value is within the healthy range. It has increased from 38.86 (Mar 24) to 38.90, marking an increase of 0.04.
• For Diluted EPS (Rs.), as of Mar 25, the value is 38.90. This value is within the healthy range. It has increased from 38.86 (Mar 24) to 38.90, marking an increase of 0.04.
• For Cash EPS (Rs.), as of Mar 25, the value is 52.30. This value is within the healthy range. It has increased from 50.49 (Mar 24) to 52.30, marking an increase of 1.81.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 177.34. It has increased from 141.18 (Mar 24) to 177.34, marking an increase of 36.16.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 177.34. It has increased from 141.18 (Mar 24) to 177.34, marking an increase of 36.16.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 268.30. It has increased from 245.56 (Mar 24) to 268.30, marking an increase of 22.74.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 66.96. This value is within the healthy range. It has increased from 60.07 (Mar 24) to 66.96, marking an increase of 6.89.
• For PBIT / Share (Rs.), as of Mar 25, the value is 53.35. This value is within the healthy range. It has increased from 48.22 (Mar 24) to 53.35, marking an increase of 5.13.
• For PBT / Share (Rs.), as of Mar 25, the value is 45.78. This value is within the healthy range. It has increased from 43.48 (Mar 24) to 45.78, marking an increase of 2.30.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 38.69. This value is within the healthy range. It has increased from 38.64 (Mar 24) to 38.69, marking an increase of 0.05.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 38.66. This value is within the healthy range. It has increased from 38.62 (Mar 24) to 38.66, marking an increase of 0.04.
• For PBDIT Margin (%), as of Mar 25, the value is 24.95. This value is within the healthy range. It has increased from 24.46 (Mar 24) to 24.95, marking an increase of 0.49.
• For PBIT Margin (%), as of Mar 25, the value is 19.88. This value is within the healthy range. It has increased from 19.63 (Mar 24) to 19.88, marking an increase of 0.25.
• For PBT Margin (%), as of Mar 25, the value is 17.06. This value is within the healthy range. It has decreased from 17.70 (Mar 24) to 17.06, marking a decrease of 0.64.
• For Net Profit Margin (%), as of Mar 25, the value is 14.41. This value exceeds the healthy maximum of 10. It has decreased from 15.73 (Mar 24) to 14.41, marking a decrease of 1.32.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.41. This value is within the healthy range. It has decreased from 15.72 (Mar 24) to 14.41, marking a decrease of 1.31.
• For Return on Networth / Equity (%), as of Mar 25, the value is 21.80. This value is within the healthy range. It has decreased from 27.36 (Mar 24) to 21.80, marking a decrease of 5.56.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.95. This value is within the healthy range. It has decreased from 21.82 (Mar 24) to 17.95, marking a decrease of 3.87.
• For Return On Assets (%), as of Mar 25, the value is 10.87. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 10.87, marking a decrease of 3.16.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has increased from 0.41 (Mar 24) to 0.54, marking an increase of 0.13.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.61. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 0.61, marking an increase of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has decreased from 1.03 (Mar 24) to 0.85, marking a decrease of 0.18.
• For Current Ratio (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has increased from 1.75 (Mar 24) to 2.14, marking an increase of 0.39.
• For Quick Ratio (X), as of Mar 25, the value is 2.04. This value exceeds the healthy maximum of 2. It has increased from 1.65 (Mar 24) to 2.04, marking an increase of 0.39.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 49.80. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 49.80, marking an increase of 49.80.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 10.28. This value is below the healthy minimum of 20. It has increased from 6.43 (Mar 24) to 10.28, marking an increase of 3.85.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.60. This value is below the healthy minimum of 20. It has increased from 4.92 (Mar 24) to 7.60, marking an increase of 2.68.
• For Earning Retention Ratio (%), as of Mar 25, the value is 89.72. This value exceeds the healthy maximum of 70. It has decreased from 93.57 (Mar 24) to 89.72, marking a decrease of 3.85.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.40. This value exceeds the healthy maximum of 70. It has decreased from 95.08 (Mar 24) to 92.40, marking a decrease of 2.68.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 9.35. This value is within the healthy range. It has decreased from 12.67 (Mar 24) to 9.35, marking a decrease of 3.32.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.45. This value is within the healthy range. It has decreased from 9.15 (Mar 24) to 6.45, marking a decrease of 2.70.
• For Enterprise Value (Cr.), as of Mar 25, the value is 36,133.09. It has increased from 27,191.98 (Mar 24) to 36,133.09, marking an increase of 8,941.11.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.59. This value exceeds the healthy maximum of 3. It has increased from 5.42 (Mar 24) to 6.59, marking an increase of 1.17.
• For EV / EBITDA (X), as of Mar 25, the value is 26.40. This value exceeds the healthy maximum of 15. It has increased from 22.15 (Mar 24) to 26.40, marking an increase of 4.25.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.30. This value exceeds the healthy maximum of 3. It has increased from 5.21 (Mar 24) to 6.30, marking an increase of 1.09.
• For Retention Ratios (%), as of Mar 25, the value is 89.71. This value exceeds the healthy maximum of 70. It has decreased from 93.56 (Mar 24) to 89.71, marking a decrease of 3.85.
• For Price / BV (X), as of Mar 25, the value is 9.54. This value exceeds the healthy maximum of 3. It has increased from 9.07 (Mar 24) to 9.54, marking an increase of 0.47.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.30. This value exceeds the healthy maximum of 3. It has increased from 5.21 (Mar 24) to 6.30, marking an increase of 1.09.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness